MedPath

Corza Medical GmbH

Corza Medical GmbH logo
πŸ‡¨πŸ‡­Switzerland
Ownership
Private
Established
2021-01-01
Employees
1K
Market Cap
-
Website
https://corza.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

11

CANADA:3
CIMA_AEMPS:3
FDA:1
+1 more agencies

Drug Approvals

TachoSil

Approval Date
Sep 1, 2023
FDA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 3
1 (100.0%)

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

Phase 3
Recruiting
Conditions
Hemorrhage
Interventions
Biological: Surgicel Original
First Posted Date
2024-10-30
Last Posted Date
2025-10-06
Lead Sponsor
Corza Medical GmbH
Target Recruit Count
116
Registration Number
NCT06664775
Locations
πŸ‡ΊπŸ‡Έ

Torrance Memorial, Torrance, California, United States

πŸ‡ΊπŸ‡Έ

St. Anthony Hospital, Lakewood, Colorado, United States

πŸ‡ΊπŸ‡Έ

Georgetown University, Washington D.C., District of Columbia, United States

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.